ua
ru
en
REHAU cancels participation in the replacement date of the Frontale 2020

REHAU cancels participation in the replacement date of the Frontale 2020

fensterbau/frontale 2022
Safety first. "For us, the health and safety of employees, customers and partners is our top priority," explains Carsten Heuer, Division Manager Window Solutions and member of the REHAU management board. "Taking into account the official assessment of the current situation regarding the corona virus and the as yet unforeseeable further development, we are cancelling our participation in Fensterbau Frontale 2020. By cancelling, we are taking a far-reaching precautionary measure for the protection and well-being of people. The most important task at the moment is to minimise the risk of further spread and we are following this consequently". Of course, the cancellation is not easy for REHAU. "We regret this step, as the Frontale has been a very important event for us for decades for the personal presentation of our innovations and new products to our customers, partners and visitors. However, in the current situation, we see no alternative to the cancellation, since REHAU's focus is on the health and safety of people," emphasizes Carsten Heuer.

REHAU consistently pursues the goal of presenting trend-setting innovations in and around the window to its customers and interested parties, which create considerable added value and can benefit the customer in line with the motto "Create difference, grow business". In doing so, REHAU provides answers to many of the challenges that are driving the industry - be it smart technologies, the continuing shortage of skilled workers or digitization. In addition, the product portfolio will be expanded to include clever solution packages beyond profile systems in the sense of a holistic system provider. REHAU will now provide regular information in order to present all of these innovations in detail to the specialist world - even without this year's trade fair.
The editorial opinion may differ from the opinion of the author.
0800 308 88 XX XX 0800 308 888
0800 308 88 XX XX +380 50 150 4942
ID no: 20864